Peripheral NeuropathyNCT07055711
Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Post CT
An observational study of Peripheral Neuropathy, run by Superior University at 1 site in Pakistan.
Trial summary
This research aims to find the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy. Read more about this study
- Who is it for?
- Ages 21 to 51 years, women only
- Conditions the study is for
- Peripheral Neuropathy
- What is being tested?
- Peripheral Neuropathic Pain
- How many people
- 45 participants
- Where
- 1 sitePakistan
- Study dates
- 3 Mar 2025to 1 Sep 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 51 years
- Women only
- No healthy volunteers
- Adult
Study population: to find out the Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer
Who may be able to join
- Females who have completed chemotherapy at least o1 year prior to study.
- Aged 29-51.
- Females who is currently employed.
- Females who have done chemotherapy for stage 1,2,3.
- Females who underwent chemotherapy cycles 6-8.
- Females who are willing to participate in the study
Who cannot join
- Females suffering from psychiatric conditions such as anxiety and depression.
- Females suffering from diabetes.
- Females who have active cancer.
- Females with mastectomy.
- Absent from treatment for more than 2 weeks will be excluded from the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Survivors Post-Chemotherapy
This research aims to find the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.
- Conditions
- Peripheral Neuropathy
- Being tested
- Peripheral Neuropathic Pain
- Medical subject headings
- Peripheral Nervous System Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Peripheral Neuropathic PainDiagnostic test
to find out the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.
What is being measured
The primary outcome is the main question the study is designed to answer.
Douleur Neuropathique 4 (DN4) Questionnaire
The DN4 questionnaire is used to assess the neuropathic pain, if the score is > 4 it indicates the neuropathic pain is present while <3 than is unlikely.
Measured: 6 Month
visual analog scale
The visual analog scale provide quantitative measurement of pain level which is from no pain to severe pain . The range of the scale is in between 0-10mm. 0-4 is consider as no pain, 5-44 is consider as mild pain,45-74 is moderate and > 75 is consider as severe pain.
Measured: 6 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jul 2025
- Study start3 Mar 2025
- Primary completion1 Jun 2025
- Study completion1 Sep 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Peripheral NeuropathyStudies of the same condition, open and under way.
- More trials run by Superior UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Retrospective
- Enrolment
- 45 participants (actual)
Sponsor and investigators
- Lead sponsor
- Superior University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Muhammad Naveed Babur, Superior University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07055711
- Sponsor's protocol ID
- DPT/Batch-Fall20/1016
- Status last verified
- Jun 2025
- First submitted
- 28 Jun 2025
- Last updated
- 9 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Survivors Post-Chemotherapy
- ClinicalTrials.gov ID
- NCT07055711
- Acronym / sponsor ID
- DPT/Batch-Fall20/1016
- Conditions
- Peripheral Neuropathy
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 45 participants (actual)
- Lead sponsor
- Superior UniversityUniversity, hospital or other
- Study start
- 3 Mar 2025 (actual)
- Primary completion
- 1 Jun 2025 (actual)
- Study completion
- 1 Sep 2025 (estimated)
- First posted
- 9 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This research aims to find the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.
Study design
- Observational model
- Case-control
- Time perspective
- Retrospective
Who may qualify
- Ages
- 21 to 51 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- to find out the Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer
Key inclusion criteria (6 listed)
- Females who have completed chemotherapy at least o1 year prior to study.
- Aged 29-51.
- Females who is currently employed.
- Females who have done chemotherapy for stage 1,2,3.
- Females who underwent chemotherapy cycles 6-8.
Key exclusion criteria (5 listed)
- Females suffering from psychiatric conditions such as anxiety and depression.
- Females suffering from diabetes.
- Females who have active cancer.
- Females with mastectomy.
- Absent from treatment for more than 2 weeks will be excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Peripheral Neuropathic Painto find out the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy. | Diagnostic test | – |
Primary outcome
Douleur Neuropathique 4 (DN4) Questionnaire
Time frame: 6 Month
The DN4 questionnaire is used to assess the neuropathic pain, if the score is > 4 it indicates the neuropathic pain is present while <3 than is unlikely.
visual analog scale
Time frame: 6 Months
The visual analog scale provide quantitative measurement of pain level which is from no pain to severe pain . The range of the scale is in between 0-10mm. 0-4 is consider as no pain, 5-44 is consider as mild pain,45-74 is moderate and > 75 is consider as severe pain.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Peripheral Neuropathy
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
RecruitingObservational study
Pain Phenotypes in Individuals With Multiple Sclerosis
Multiple Sclerosis, Chronic Pain
Not yet recruitingObservational study
Postural Control and Balance Performance in Patients With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Postural Assessment
Active, not recruiting
The AIUR Trial: Surgical Gloves to Prevent Peripheral Neuropathy
Chemotherapy-induced Peripheral Neuropathy
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Peripheral Neuropathy, run by Superior University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 9 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Douleur Neuropathique 4 (DN4) Questionnaire (time frame: 6 Month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2025.